Summary of Fresh and Frozen Embryo Transfer Outcomes
Fresh vs. Frozen Embryo Transfer Outcomes: An SEO Guide
Introduction
Embryo transfer is a core step in assisted reproductive technology (ART). Clinicians decide whether to transfer embryos in the same stimulated cycle (fresh transfer) or to cryopreserve embryos and transfer them later in a subsequent cycle (freeze-all followed by frozen embryo transfer). Each strategy has trade-offs in timing, maternal risks, pregnancy outcomes, and logistics. This material explains the clinical context, evidence from trials, risk considerations, and practical decision points for selecting a transfer strategy.
Definition: Fresh embryo transfer — transferring one or more embryos into the uterus during the same ovarian stimulation cycle from which the oocytes were collected.
Definition: Freeze-all strategy — cryopreserving all viable embryos after fertilisation and performing embryo transfer in a later cycle after embryo thawing.
Background and historical context
- Early ART eras had no routine embryo freezing; the first reported live birth from a frozen embryo transfer (FET) was in 1983 in Australia. Before reliable cryopreservation, clinics commonly transferred multiple embryos immediately and discarded excess embryos.
- The shift to embryo freezing enabled elective single embryo transfer (eSET), lower multiple birth rates, and staged family planning with stored embryos.
Key clinical problems addressed by transfer strategy
- Multiple pregnancy risks (twins, triplets): increased miscarriage, preterm birth, gestational diabetes, pregnancy-induced hypertension and preeclampsia.
- Ovarian Hyperstimulation Syndrome (OHSS): a serious iatrogenic complication tied to ovarian stimulation intensity.
- Endometrial receptivity: ovarian stimulation and supraphysiologic hormone levels can alter the endometrial environment and potentially affect implantation.
Comparing fresh transfer and freeze-all then FET
Advantages and disadvantages (table)
| Aspect | Fresh transfer | Freeze-all then FET |
|---|---|---|
| Time to pregnancy | Shorter | Longer (delay to first transfer) |
| Steps/procedures | Fewer | More steps (cryopreservation, thaw, scheduling) |
| Cost | Typically lower | More costly (storage, additional procedures) |
| OHSS mitigation | No direct mitigation | Can reduce OHSS risk when trigger & embryo freezing strategies used |
| Potential implantation environment | May be altered by stimulation hormones | Performed in a more physiologic or controlled endometrial environment |
| Error risk | Fewer steps, fewer handoffs | More steps, potentially more opportunities for logistical errors |
When freeze-all is clearly indicated
- Women at high risk of OHSS (for example, polycystic ovarian syndrome (PCOS) with large oocyte yield or very high estradiol levels) — freeze-all can prevent or reduce OHSS by postponing transfer and allowing luteal recovery.
Evidence summary from randomized controlled trials
- In PCOS patients (N≈1,508 in a large trial), freeze-all then FET produced a higher live birth rate compared with fresh transfer in that population. Outcomes reported included higher birth weight and lower OHSS and preeclampsia rates in the frozen group.
- In general ovulatory women (large RCT N≈2,157), overall live birth rates between fresh and freeze-all strategies were similar. Observed differences included a tendency toward heavier babies in FET and variable effects on preeclampsia and OHSS.
- Smaller RCTs in non-PCOS populations showed mixed results with no consistent advantage for freeze-all in live birth rate; some trials reported slightly higher singleton birth weights after FET.
Definition: Randomised controlled trial (RCT) — a study design in which participants are randomly allocated to one of two or more clinical interventions to compare outcomes while minimising bias.
Interpreting the trial data (practi
Zaregistruj se pro celé shrnutíAlready have an account? Sign in
Embryo Transfer Strategies
Klíčové pojmy: Freeze-all reduces OHSS risk and benefits high responders such as many PCOS patients, In PCOS populations, freeze-all has shown higher live birth rates in large RCTs, In normal ovulatory women, freeze-all and fresh strategies yield similar live birth rates in many trials, Elevated progesterone on trigger day is a common criterion to convert to freeze-all, Vitrification is the preferred cryopreservation method due to better survival than slow freezing, Elective single embryo transfer reduces multiple birth risk while preserving cumulative live birth via frozen embryos, Freeze-all increases time to pregnancy and costs and involves more procedural steps, Decision should be individualized based on ovarian response, hormone levels, embryo quality, and patient preference, Historical multiple embryo transfer increased preterm birth and maternal complications, Trial results often used day-3, double embryo transfer, limiting direct application to modern blastocyst eSET practices